风湿肌肉骨骼疾病中甲氨蝶呤骨病的临床特征:一项系统综述
该系统综述按PRISMA指南检索MEDLINE和Embase,纳入32项研究共80例成人风湿肌肉骨骼疾病患者,描述甲氨蝶呤骨病表现为下肢非创伤性应力性骨折,常见于长期患病的老年女性(类风湿关节炎占72.5%),多累及胫骨远端(51.3%)、跟骨(35.0%)和胫骨近端(27.5%),部分可模仿关节炎。
要点
- 甲氨蝶呤骨病多表现为下肢应力性骨折,可模仿关节炎,常见于长期患病的老年女性风湿肌肉骨骼疾病患者。
- 骨折多为双侧(55.0%)、多发(71.3%)和复发(25.0%),主要发生于低至中等剂量甲氨蝶呤治疗时(45.0%)。
- 48.8%的患者至少3年未接受全身性类固醇治疗,提示骨病并非仅由类固醇所致。
核心结论
- 低剂量甲氨蝶呤治疗在风湿肌肉骨骼疾病中可能导致下肢非创伤性应力性骨折,可模仿关节炎。
- 甲氨蝶呤骨病的特征是沿生长板呈带状或蜿蜒状外观的特征性应力性骨折。
研究设计与样本
- 按PRISMA指南进行的系统综述,检索MEDLINE和Embase两个数据库,纳入32项研究共80例成人风湿肌肉骨骼疾病患者。
- 对纳入文献的数据进行提取并作描述性统计分析。
主要发现
- 多数病例为长期患风湿肌肉骨骼疾病的老年女性,类风湿关节炎占72.5%。
- 甲氨蝶呤骨病常表现为胫骨远端应力性骨折(51.3%)、跟骨(35.0%)和胫骨近端(27.5%),部分病例模仿关节炎。
- 58.1%的患者符合骨密度测定的骨质疏松标准,但典型骨质疏松性骨折(如椎体骨折)罕见。
- 患者常发生双侧(55.0%)、多发(71.3%)和复发性骨折(25.0%)。
- 骨折主要发生于低至中等剂量甲氨蝶呤治疗时(45.0%);48.8%的患者至少3年未接受全身性类固醇治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is growing evidence from case reports that methotrexate (MTX) therapy may impair bone metabolism in individual patients leading to low bone mass, atraumatic stress fractures and immobilizing bone pain - referred to as 'MTX osteopathy'. However, the clinical features, risk factors and treatment options of this condition are still elusive. METHODS: A systematic review was conducted according to PRISMA guidelines. Two databases (MEDLINE, Embase) were searched for published cases of MTX osteopathy in patients with rheumatic musculoskeletal diseases (RMD). Data from the included publications were extracted and descriptive statistical analysis was performed. RESULTS: We report data from 32 studies describing 80 adult RMD patients with stress fractures in MTX osteopathy. Most cases were found in elderly women with longstanding RMD, especially rheumatoid arthritis (72.5%). MTX osteopathy commonly presented as stress fracture of the distal tibia (51.3%), calcaneus (35.0%) and proximal tibia (27.5%), mimicking arthritis in some cases. Although a majority of the patients met the densitometric criteria for osteoporosis (58.1%), typical osteoporotic fractures (e.g., vertebral fractures) were rarely seen. Patients frequently suffered from bilateral (55.0%), multiple (71.3%) and recurrent fractures (25.0%). Fractures mainly occurred at low to moderate doses of MTX therapy (45.0%). It should be noted that half (48.8%) of the patients did not receive systemic steroid therapy for at least 3 years. CONCLUSIONS: Low-dose MTX therapy in RMD may result in atraumatic stress fractures of the lower extremity that can mimic arthritis. MTX osteopathy is characterized by a pathognomonic type of stress fractures with band- or meander-shaped appearance along the growth plate.
引用
- Ruffer N, Krusche M, Beil FT, et al. Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review. Semin Arthritis Rheum. 2022. PMID: 35038641. doi:10.1016/j.semarthrit.2022.151952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。